Diabetes drug Mounjaro found to cut heart attack risk by a third for first time

Those receiving the drug were found to be 33 per cent less likely to suffer a heart attack when compared to patients on another type 2 diabetes medication

WEIGHT loss jab Mounjaro could slash the risk of life-threatening heart attacks, a study suggests. Tirzepatide, the powerful ingredient behind Mounjaro, has long been been hailed a monumental breakthrough in the war on obesity and type 2 diabetes. Now, US researchers have found that those taking the jab were 33 per cen